Answers are grounded in this paper and cite their sources.
This article reviews intestinal transplantation and its situation in Mexico. Intestinal transplantation is described as the primary treatment option for eligible patients with severe gastrointestinal diseases, including inflammatory bowel diseases, acute mesenteric infarction and refractory end-stage intestinal failure, although up to 44% of recipients die within 5 to 10 years. The article outlines its history, from Alexis Carrel's pioneering work and the first canine model of isolated intestinal transplantation in 1959 to the first human intestinal transplant, performed by Lillehei in 1967. It cites the World Health Organization's Global Observatory on Donation and Transplantation, which reported 157,494 transplants in 2022, of which 170 were intestinal, mostly performed in England and the United States, with only sporadic cases in Latin America, including two in Mexico. The authors state that in Mexico intestinal transplantation has been documented as successful only in unpublished and anecdotal form, that no long-term survival has been reported and that no tangible results of the procedure have been publicly evidenced. The article also discusses short bowel syndrome, including the difficulty of defining it by residual intestinal length, its causes in adults and children, such as very high stomas created in emergency or damage-control surgery, and the dependence on artificial nutrition and risk of refeeding syndrome in patients who have not achieved intestinal adaptation. Abstract prepared by the editorial office from the full text of the article; the authors did not supply one.
No takes yet. Share an insight, caveat, or question.
Morelos Adolfo García Sánchez (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: